• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

TPLC - Total Product Life Cycle

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search show TPLC since Back to Search Results
Device hydrogel spacer
Definition The perirectal spacer is intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of the perirectal spacer to reduce the radiation dose delivered to the anterior rectum. The perirectal spacer is composed of biodegradable material and maintains space for the entire course of prostate radiotherapy treatment and is completely absorbed by the patient’s body over time.
Product CodeOVB
Regulation Number 892.5725
Device Class 2


Premarket Reviews
ManufacturerDecision
AUGMENIX, INC
  SUBSTANTIALLY EQUIVALENT 1
AUGMENIX, INC.
  SUBSTANTIALLY EQUIVALENT 1
BIOPROTECT, LTD.
  SUBSTANTIALLY EQUIVALENT 1
BOSTON SCIENTIFIC CORPORATION
  SUBSTANTIALLY EQUIVALENT 1
PALETTE LIFE SCIENCES
  SUBSTANTIALLY EQUIVALENT 1

MDR Year MDR Reports MDR Events
2018 11 11
2019 85 85
2020 126 126
2021 272 272
2022 387 387
2023 327 327
2024 217 217

Device Problems MDRs with this Device Problem Events in those MDRs
Positioning Problem 1046 1046
Adverse Event Without Identified Device or Use Problem 305 305
Material Integrity Problem 29 29
Defective Device 28 28
Obstruction of Flow 17 17
Device Contamination with Chemical or Other Material 16 16
Inadequacy of Device Shape and/or Size 13 13
Migration 12 12
Use of Device Problem 12 12
Appropriate Term/Code Not Available 12 12
Material Deformation 7 7
Insufficient Information 7 7
Improper or Incorrect Procedure or Method 5 5
Malposition of Device 2 2
Connection Problem 2 2
Fluid/Blood Leak 2 2
Device-Device Incompatibility 2 2
Unsealed Device Packaging 2 2
Contamination 2 2
Device Dislodged or Dislocated 2 2
Loose or Intermittent Connection 2 2
Off-Label Use 1 1
Packaging Problem 1 1
Product Quality Problem 1 1
Missing Value Reason 1 1
Inadequate or Insufficient Training 1 1
Leak/Splash 1 1
Device Contaminated During Manufacture or Shipping 1 1
Patient-Device Incompatibility 1 1
Patient Device Interaction Problem 1 1

Patient Problems MDRs with this Patient Problem Events in those MDRs
No Clinical Signs, Symptoms or Conditions 606 606
Pain 298 298
Discomfort 183 183
Fistula 135 135
Abscess 121 121
Hemorrhage/Bleeding 112 112
Fluid Discharge 106 106
Inflammation 98 98
Ulcer 93 93
Unspecified Infection 83 83
No Consequences Or Impact To Patient 70 70
Urinary Retention 67 67
Constipation 63 63
Fever 54 54
Perforation 51 51
Insufficient Information 42 42
Hypersensitivity/Allergic reaction 36 36
Swelling/ Edema 35 35
Diarrhea 30 30
Urinary Frequency 27 27
No Code Available 18 18
Micturition Urgency 17 17
Dysuria 17 17
Injury 16 16
Necrosis 16 16
Unspecified Kidney or Urinary Problem 15 15
Obstruction/Occlusion 15 15
Urinary Tract Infection 14 14
Cramp(s) /Muscle Spasm(s) 14 14
Nausea 13 13
Hematoma 13 13
Syncope/Fainting 13 13
Hematuria 12 12
Loss of consciousness 12 12
Rash 12 12
Low Blood Pressure/ Hypotension 12 12
Skin Inflammation/ Irritation 11 11
Erosion 11 11
Pulmonary Embolism 11 11
No Known Impact Or Consequence To Patient 11 11
Chills 10 10
Burning Sensation 10 10
Abdominal Pain 9 9
Fecal Incontinence 9 9
Embolism/Embolus 9 9
Unspecified Tissue Injury 9 9
Purulent Discharge 9 9
Cardiac Arrest 9 9
Swelling 8 8
Dizziness 8 8

Recalls
Manufacturer Recall Class Date Posted
1 Boston Scientific Corporation II Apr-25-2022
-
-